Xiuying Xiao
8PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 27, 2026
NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.Wei Zhang, Wenxin Feng, Chunxiao Ma
|Feb 26, 2026
Histone 3 lysine 36 trimethylation by SETD2 shapes an epigenetic landscape in intestinal stem cells to orchestrate lipid metabolism and attenuate cell senescence.Yue Xu, Ziyi Wang, Wenxin Feng
|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov
|Dec 10, 2024
Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.Yue Xu, Xiuying Xiao, Chunxiao Ma
|Aug 21, 2023
Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade.Yaqi Gao, Pingping Xu, Danfeng Sun
|Sep 26, 2021
CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.Xiaolin Lin, Ting Han, Qing Xia
Pageof 2
